Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lippis Daniel J. | CVP, JAPAC | May 07 '24 | Option Exercise | 36.75 | 857 | 31,495 | 25,333 | May 09 07:40 PM | Lippis Daniel J. | CVP, JAPAC | May 07 '24 | Sale | 85.60 | 857 | 73,359 | 23,890 | May 09 07:40 PM | Zovighian Bernard J | CEO | May 06 '24 | Buy | 85.74 | 580 | 49,753 | 3,268 | May 07 05:53 PM | Chopra Daveen | CVP, TMTT | May 04 '24 | Option Exercise | 0.00 | 4,713 | 0 | 27,172 | May 06 07:17 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | May 04 '24 | Option Exercise | 0.00 | 5,855 | 0 | 45,144 | May 06 07:16 PM | Ullem Scott B. | CVP, Chief Financial Officer | May 04 '24 | Option Exercise | 0.00 | 7,465 | 0 | 25,905 | May 06 07:18 PM | Szyman Catherine M. | CVP, Critical Care | May 04 '24 | Option Exercise | 0.00 | 5,796 | 0 | 49,018 | May 06 07:18 PM | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | May 04 '24 | Option Exercise | 0.00 | 4,157 | 0 | 177,969 | May 06 07:18 PM | Wood Larry L | Global President TAVR & Surg | May 04 '24 | Option Exercise | 0.00 | 6,675 | 0 | 220,022 | May 06 07:17 PM | Zovighian Bernard J | CEO | May 04 '24 | Option Exercise | 0.00 | 6,265 | 0 | 50,554 | May 07 05:53 PM | MUSSALLEM MICHAEL A | Director | May 02 '24 | Option Exercise | 36.75 | 29,350 | 1,078,612 | 33,836 | May 02 06:05 PM | MUSSALLEM MICHAEL A | Director | May 02 '24 | Sale | 84.77 | 29,350 | 2,487,966 | 4,486 | May 02 06:05 PM | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | May 01 '24 | Option Exercise | 36.75 | 14,400 | 529,200 | 188,249 | May 01 05:17 PM | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | May 01 '24 | Sale | 84.21 | 14,400 | 1,212,687 | 173,849 | May 01 05:17 PM | Ullem Scott B. | CVP, Chief Financial Officer | Apr 30 '24 | Option Exercise | 36.75 | 7,250 | 266,438 | 26,324 | Apr 30 04:56 PM | Ullem Scott B. | CVP, Chief Financial Officer | Apr 30 '24 | Sale | 85.80 | 7,250 | 622,062 | 19,074 | Apr 30 04:56 PM | Lippis Daniel J. | CVP, JAPAC | Apr 09 '24 | Option Exercise | 36.75 | 857 | 31,495 | 18,345 | Apr 09 05:33 PM | Lippis Daniel J. | CVP, JAPAC | Apr 09 '24 | Sale | 92.34 | 857 | 79,135 | 17,488 | Apr 09 05:33 PM | Lemercier Jean-Luc M | CVP, EMEACLA | Apr 08 '24 | Option Exercise | 36.75 | 14,400 | 529,200 | 188,249 | Apr 08 05:10 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Apr 08 '24 | Option Exercise | 36.75 | 12,500 | 459,375 | 52,268 | Apr 08 05:10 PM | Lemercier Jean-Luc M | CVP, EMEACLA | Apr 08 '24 | Sale | 92.32 | 14,400 | 1,329,472 | 173,849 | Apr 08 05:10 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Apr 08 '24 | Sale | 92.33 | 12,500 | 1,154,142 | 39,768 | Apr 08 05:10 PM | MUSSALLEM MICHAEL A | Director | Apr 04 '24 | Option Exercise | 36.75 | 29,350 | 1,078,612 | 33,836 | Apr 04 06:26 PM | MUSSALLEM MICHAEL A | Director | Apr 04 '24 | Sale | 92.42 | 29,350 | 2,712,418 | 4,486 | Apr 04 06:26 PM | Ullem Scott B. | CVP, Chief Financial Officer | Apr 01 '24 | Option Exercise | 36.75 | 7,255 | 266,621 | 26,329 | Apr 01 06:55 PM | Ullem Scott B. | CVP, Chief Financial Officer | Apr 01 '24 | Sale | 94.89 | 7,255 | 688,423 | 19,074 | Apr 01 06:55 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Mar 13 '24 | Option Exercise | 36.75 | 14,500 | 532,875 | 54,003 | Mar 13 05:44 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Mar 13 '24 | Sale | 91.01 | 14,500 | 1,319,696 | 39,503 | Mar 13 05:44 PM | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | Mar 11 '24 | Option Exercise | 36.75 | 14,400 | 529,200 | 187,984 | Mar 11 06:00 PM | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | Mar 11 '24 | Sale | 91.68 | 14,400 | 1,320,149 | 173,584 | Mar 11 06:00 PM | Lippis Daniel J. | CVP, JAPAC | Mar 07 '24 | Option Exercise | 36.75 | 1,715 | 63,026 | 18,928 | Mar 07 06:22 PM | Lippis Daniel J. | CVP, JAPAC | Mar 07 '24 | Sale | 90.98 | 1,715 | 156,031 | 17,213 | Mar 07 06:22 PM | MUSSALLEM MICHAEL A | Director | Mar 04 '24 | Option Exercise | 36.75 | 29,350 | 1,078,612 | 33,836 | Mar 04 07:16 PM | MUSSALLEM MICHAEL A | Director | Mar 04 '24 | Sale | 86.67 | 29,350 | 2,543,737 | 4,486 | Mar 04 07:16 PM | Ullem Scott B. | CVP, Chief Financial Officer | Feb 29 '24 | Option Exercise | 36.75 | 7,255 | 266,621 | 26,329 | Feb 29 05:12 PM | Ullem Scott B. | CVP, Chief Financial Officer | Feb 29 '24 | Sale | 85.59 | 7,255 | 620,923 | 19,074 | Feb 29 05:12 PM | GALLAHUE KIERAN | Director | Feb 23 '24 | Option Exercise | 36.86 | 7,056 | 260,107 | 10,757 | Feb 26 05:52 PM | GALLAHUE KIERAN | Director | Feb 23 '24 | Sale | 87.61 | 3,058 | 267,911 | 67,219 | Feb 26 05:52 PM | Chopra Daveen | CVP, TMTT | Feb 21 '24 | Option Exercise | 59.26 | 7,000 | 414,797 | 30,950 | Feb 21 05:52 PM | Chopra Daveen | CVP, TMTT | Feb 21 '24 | Sale | 86.74 | 8,200 | 711,272 | 22,750 | Feb 21 05:52 PM | Szyman Catherine M. | CVP, Critical Care | Feb 15 '24 | Option Exercise | 36.75 | 27,000 | 992,250 | 61,814 | Feb 15 05:25 PM | Szyman Catherine M. | CVP, Critical Care | Feb 15 '24 | Sale | 85.62 | 27,000 | 2,311,654 | 34,814 | Feb 15 05:25 PM | Szyman Catherine M. | CVP, Critical Care | Feb 13 '24 | Option Exercise | 36.75 | 20,000 | 735,000 | 54,814 | Feb 15 05:25 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Feb 13 '24 | Option Exercise | 36.75 | 11,000 | 404,250 | 50,503 | Feb 13 04:51 PM | Szyman Catherine M. | CVP, Critical Care | Feb 13 '24 | Sale | 86.46 | 20,000 | 1,729,200 | 34,814 | Feb 15 05:25 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Feb 13 '24 | Sale | 85.83 | 11,000 | 944,155 | 39,503 | Feb 13 04:51 PM | SELLERS ROBERT W.A. | SVP, Corporate Controller | Feb 12 '24 | Option Exercise | 36.75 | 12,210 | 448,718 | 25,297 | Feb 12 05:44 PM | SELLERS ROBERT W.A. | SVP, Corporate Controller | Feb 12 '24 | Sale | 87.00 | 12,210 | 1,062,270 | 13,087 | Feb 12 05:44 PM | STONE HEISZ LESLIE | Director | Feb 08 '24 | Option Exercise | 36.86 | 7,056 | 260,107 | 34,036 | Feb 08 06:08 PM | STONE HEISZ LESLIE | Director | Feb 08 '24 | Sale | 86.45 | 7,056 | 609,991 | 26,980 | Feb 08 06:08 PM | MUSSALLEM MICHAEL A | Director | Feb 05 '24 | Option Exercise | 36.75 | 29,350 | 1,078,612 | 33,836 | Feb 05 06:37 PM | MUSSALLEM MICHAEL A | Director | Feb 05 '24 | Sale | 87.49 | 29,350 | 2,567,754 | 4,486 | Feb 05 06:37 PM | Ullem Scott B. | CVP, Chief Financial Officer | Feb 01 '24 | Option Exercise | 36.75 | 7,255 | 266,621 | 26,503 | Feb 01 05:52 PM | Ullem Scott B. | CVP, Chief Financial Officer | Feb 01 '24 | Sale | 78.29 | 7,255 | 567,994 | 19,248 | Feb 01 05:52 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Jan 12 '24 | Option Exercise | 36.75 | 10,000 | 367,500 | 49,503 | Jan 12 05:36 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Jan 12 '24 | Sale | 75.67 | 10,000 | 756,700 | 39,503 | Jan 12 05:36 PM | MUSSALLEM MICHAEL A | Director | Jan 05 '24 | Option Exercise | 36.75 | 29,350 | 1,078,612 | 33,836 | Jan 05 07:19 PM | MUSSALLEM MICHAEL A | Director | Jan 05 '24 | Sale | 72.98 | 29,350 | 2,142,089 | 4,486 | Jan 05 07:19 PM | Ullem Scott B. | CVP, Chief Financial Officer | Dec 29 '23 | Option Exercise | 36.75 | 14,510 | 533,242 | 33,758 | Dec 29 04:25 PM | Ullem Scott B. | CVP, Chief Financial Officer | Dec 29 '23 | Sale | 76.55 | 14,510 | 1,110,794 | 19,248 | Dec 29 04:25 PM | Chopra Daveen | CVP, TMTT | Dec 15 '23 | Option Exercise | 59.26 | 7,000 | 414,797 | 30,950 | Dec 15 05:22 PM | Chopra Daveen | CVP, TMTT | Dec 15 '23 | Sale | 78.25 | 7,000 | 547,724 | 23,950 | Dec 15 05:22 PM | MUSSALLEM MICHAEL A | Director | Dec 13 '23 | Option Exercise | 36.75 | 29,350 | 1,078,612 | 33,836 | Dec 13 07:04 PM | Wood Larry L | Global President TAVR & Surg | Dec 13 '23 | Option Exercise | 45.28 | 8,658 | 392,006 | 222,452 | Dec 13 07:04 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Dec 13 '23 | Option Exercise | 36.75 | 8,000 | 294,000 | 47,503 | Dec 13 07:04 PM | MUSSALLEM MICHAEL A | Director | Dec 13 '23 | Sale | 74.62 | 29,350 | 2,190,043 | 4,486 | Dec 13 07:04 PM | Wood Larry L | Global President TAVR & Surg | Dec 13 '23 | Sale | 71.86 | 8,658 | 622,164 | 213,794 | Dec 13 07:04 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Dec 13 '23 | Sale | 71.86 | 8,000 | 574,880 | 39,503 | Dec 13 07:04 PM | Chopra Daveen | CVP, TMTT | Dec 06 '23 | Option Exercise | 59.26 | 3,500 | 207,398 | 27,450 | Dec 06 05:01 PM | Chopra Daveen | CVP, TMTT | Dec 06 '23 | Sale | 70.00 | 3,500 | 245,006 | 23,950 | Dec 06 05:01 PM | Wood Larry L | Global President TAVR & Surg | Nov 13 '23 | Option Exercise | 45.28 | 8,660 | 392,096 | 222,454 | Nov 13 05:21 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Nov 13 '23 | Option Exercise | 36.75 | 6,000 | 220,500 | 45,503 | Nov 13 05:21 PM | Wood Larry L | Global President TAVR & Surg | Nov 13 '23 | Sale | 65.30 | 8,660 | 565,460 | 213,794 | Nov 13 05:21 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Nov 13 '23 | Sale | 65.30 | 6,000 | 391,780 | 39,503 | Nov 13 05:21 PM | MUSSALLEM MICHAEL A | Director | Nov 03 '23 | Option Exercise | 36.75 | 29,350 | 1,078,612 | 33,836 | Nov 06 06:33 PM | MUSSALLEM MICHAEL A | Director | Nov 03 '23 | Sale | 67.18 | 29,350 | 1,971,733 | 4,486 | Nov 06 06:33 PM | Ullem Scott B. | CVP, Chief Financial Officer | Oct 31 '23 | Option Exercise | 36.75 | 7,255 | 266,621 | 26,503 | Oct 31 05:22 PM | Ullem Scott B. | CVP, Chief Financial Officer | Oct 31 '23 | Sale | 62.66 | 7,255 | 454,569 | 19,248 | Oct 31 05:22 PM | Wood Larry L | Global President TAVR & Surg | Oct 13 '23 | Option Exercise | 45.28 | 8,660 | 392,096 | 222,454 | Oct 13 05:02 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Oct 13 '23 | Option Exercise | 36.75 | 5,000 | 183,750 | 44,503 | Oct 13 05:01 PM | Wood Larry L | Global President TAVR & Surg | Oct 13 '23 | Sale | 70.00 | 8,660 | 606,198 | 213,794 | Oct 13 05:02 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Oct 13 '23 | Sale | 69.98 | 5,000 | 349,909 | 39,503 | Oct 13 05:01 PM | Szyman Catherine M. | CVP, Critical Care | Oct 10 '23 | Option Exercise | 36.75 | 5,000 | 183,750 | 39,814 | Oct 10 06:23 PM | Szyman Catherine M. | CVP, Critical Care | Oct 10 '23 | Sale | 72.68 | 5,000 | 363,400 | 34,814 | Oct 10 06:23 PM | Chopra Daveen | CVP, TMTT | Oct 03 '23 | Option Exercise | 59.26 | 8,500 | 503,682 | 32,450 | Oct 03 04:58 PM | Chopra Daveen | CVP, TMTT | Oct 03 '23 | Sale | 70.00 | 8,500 | 595,000 | 23,950 | Oct 03 04:58 PM | MUSSALLEM MICHAEL A | Director | Oct 02 '23 | Option Exercise | 36.75 | 29,350 | 1,078,612 | 33,836 | Oct 02 06:51 PM | MUSSALLEM MICHAEL A | Director | Oct 02 '23 | Sale | 68.84 | 29,350 | 2,020,454 | 4,486 | Oct 02 06:51 PM | Ullem Scott B. | CVP, Chief Financial Officer | Sep 29 '23 | Option Exercise | 36.75 | 7,255 | 266,621 | 26,503 | Sep 29 04:49 PM | Ullem Scott B. | CVP, Chief Financial Officer | Sep 29 '23 | Sale | 69.54 | 7,255 | 504,527 | 19,248 | Sep 29 04:49 PM | Wood Larry L | Global President TAVR & Surg | Sep 14 '23 | Option Exercise | 45.28 | 8,660 | 392,096 | 222,454 | Sep 14 08:00 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sep 14 '23 | Option Exercise | 36.75 | 4,500 | 165,375 | 44,003 | Sep 14 08:00 PM | Wood Larry L | Global President TAVR & Surg | Sep 14 '23 | Sale | 73.63 | 8,660 | 637,615 | 213,794 | Sep 14 08:00 PM | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sep 14 '23 | Sale | 73.71 | 4,500 | 331,695 | 39,503 | Sep 14 08:00 PM | Szyman Catherine M. | CVP, Critical Care | Sep 08 '23 | Option Exercise | 36.75 | 5,000 | 183,750 | 39,814 | Sep 08 05:29 PM | Szyman Catherine M. | CVP, Critical Care | Sep 08 '23 | Sale | 76.00 | 5,000 | 380,000 | 34,814 | Sep 08 05:29 PM | Chopra Daveen | CVP, TMTT | Sep 06 '23 | Option Exercise | 59.26 | 8,500 | 503,682 | 32,450 | Sep 06 05:09 PM | Chopra Daveen | CVP, TMTT | Sep 06 '23 | Sale | 76.07 | 8,500 | 646,609 | 23,950 | Sep 06 05:09 PM | MUSSALLEM MICHAEL A | Director | Sep 05 '23 | Option Exercise | 36.75 | 29,350 | 1,078,612 | 33,836 | Sep 05 07:08 PM | MUSSALLEM MICHAEL A | Director | Sep 05 '23 | Sale | 75.86 | 29,350 | 2,226,491 | 4,486 | Sep 05 07:08 PM |
|